[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The EGFR protein is a receptor tyrosine kinase involved in cell growth and proliferation. Mutations in EGFR, such as the L858R variant, can lead to constitutive activation of the receptor, driving uncontrolled cell growth and tumor formation.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states the role of EGFR mutations in driving uncontrolled cell growth and tumor formation.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Protein interaction assays are used to determine the conformational changes and downstream signaling effects of EGFR mutations, such as L858R, in the context of receptor dimerization and kinase activity.",
        "judgment": "Yes",
        "reasoning": "Protein interaction assays are directly applicable to understanding the functional consequences of EGFR mutations on downstream signaling pathways.",
        "next_step_or_outcome": "Proceed to Step 2a"
      },
      {
        "step_name": "Step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "Wild-type EGFR and an empty vector control were used to establish baseline signaling levels. The experiment was performed in triplicate.",
        "judgment": "Yes",
        "reasoning": "Both 'normal' (wild-type) and 'abnormal' (empty vector) controls were used, and replicates were performed.",
        "next_step_or_outcome": "Proceed to Step 3c"
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "Comparisons were made with other documented EGFR mutations and a previously characterized loss-of-function mutant to benchmark the impact of L858R on protein interaction and kinase activity.",
        "judgment": "Yes",
        "reasoning": "The paper uses other documented mutations to act as controls, demonstrating the benchmarking and differentiation of this variantâ€™s impact.",
        "next_step_or_outcome": "Proceed to Step 3d"
      },
      {
        "step_name": "Step 3d: Statistical Analyses",
        "extracted_paper_info": "A p-value of <0.01 was determined to be statistically significant for the EGFR L858R mutant compared to the wild-type control, suggesting significant increase in kinase activity.",
        "judgment": "Yes",
        "reasoning": "The paper provides a statistical measure (p-value) to quantify the observed difference in protein interaction.",
        "next_step_or_outcome": "Proceed to Step 3e"
      },
      {
        "step_name": "Step 3e: OddsPath Calculation",
        "extracted_paper_info": "Due to experimental design constraints the OddsPath calculation for the mutant was not performed. However, comparison with other EGFR mutations with a statistically significant p-value (p < 0.01) indicated that the OddsPath was very high.",
        "judgment": "N/A",
        "reasoning": "The paper does not explicitly provide an OddsPath calculation for the EGFR L858R mutant due to experimental design constraints.",
        "next_step_or_outcome": "Proceed to Step 1a"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The EGFR L858R mutation exhibited a statistically significant increase in kinase activity, compared to the wild type. Though an OddsPath was not directly calculated, comparisons to other documented EGFR mutations suggested a very high impact on tumorigenesis, supporting its pathogenic role."
  }
]